2 results match your criteria: "Royal Brompton and Harefield NHS Trust Foundation and Imperial College[Affiliation]"
Little things make big things happen: angiolymphatic invasion and tumor necrosis prognosticate the outcome of locally advanced non-small cell lung cancer treated with a prior induction therapy.
Am J Clin Pathol
June 2015
Histopathology Department, Royal Brompton and Harefield NHS Trust Foundation and Imperial College of London, London, UK.
Objectives: Size, invasion of thoracic structures, and ipsilateral mediastinal lymph node involvement (pN2) are well-known prognostic factors that configure the staging of resectable, locally advanced non-small cell lung cancer (LA-NSCLC). The prognostic impact of angiolymphatic invasion (ALI) and tumor necrosis (TN) has been barely explored in LA-NSCLC treated with prior induction therapies.
Methods: We retrospectively reviewed 47 resected LA-NSCLCs treated with a prior platin-based chemotherapy or chemoradiation.
Transbronchial cryobiopsy in interstitial lung disease: advantageous costs to benefits ratio.
Arch Bronconeumol
June 2015
Royal Brompton and Harefield NHS Trust Foundation and Imperial College,, London, United Kingdom. Electronic address: